IP Library Granted Patent US 7,803,901
Granted Patent B2
US 7,803,901 · App. 12/065,673 · Granted Sep 28, 2010

Polypeptides with natriuresis activity

Assignee: Mayo Foundation for Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,901
App. No.
12/065,673
Granted
Sep 28, 2010
Kind
B2
Abstract

This document provides methods and material related to natriuretic polypeptides. For example, substantially pure polypeptides having a natriuretic peptide activity, nucleic acids encoding polypeptides having a natriuretic peptide activity, host cells containing such nucleic acids, and methods for inducing a natriuretic or diuretic activity within a mammal are provided.

Claims (9)

1. A substantially pure polypeptide comprising a first amino acid sequence and a second amino acid sequence, wherein said first amino acid sequence comprises the sequence of a natriuretic polypeptide having natriuresis activity, wherein said second amino acid sequence comprises the amino acid sequence as set forth in SEQ ID NO:1 or the amino acid sequence as set forth in SEQ ID NO:1 having less than five amino acid additions, subtractions, and substitutions, wherein said substantially pure polypeptide has said natriuresis activity.

2. The polypeptide of claim 1 , wherein said first amino acid sequence comprises an amino acid sequence present in an ANP polypeptide.

3. The polypeptide of claim 1 , wherein said first amino acid sequence comprises an amino acid sequence present in a BNP polypeptide.

4. The polypeptide of claim 1 , wherein said first amino acid sequence comprises an amino acid sequence present in an CNP polypeptide.

5. The polypeptide of claim 1 , wherein said first amino acid sequence comprises an amino acid sequence present in an DNP polypeptide.

6. The polypeptide of claim 1 , wherein said first amino acid sequence comprises an amino acid sequence present in a salmon natriuretic factor polypeptide.

7. The polypeptide of claim 1 , wherein said second amino acid sequence comprises the amino acid sequence as set forth in SEQ ID NO:1.

8. The polypeptide of claim 1 , wherein said second amino acid sequence comprises the amino acid sequence as set forth in SEQ ID NO:1 having less than five amino acid additions, subtractions, and substitutions.

9. The polypeptide of claim 1 , wherein said second amino acid sequence comprises the amino acid sequence as set forth in SEQ ID NO:1 having less than four amino acid additions, subtractions, and substitutions.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 26, 2012
From: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029539/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2008
From: BURNETT, JOHN C., JR.; OLSON, TIMOTHY M.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 021693/0974 →
Continuity (2)
Provisional Application 6071765500 · Sep 16, 2005
Related Publication 20090069243A1 · Mar 12, 2009